188 related articles for article (PubMed ID: 35775990)
21. [Specificity of molecular recognition in oligomerization of bacterial L-asparaginases].
Mezentsev IuV; Mol'nar AA; Sokolov NN; Lisitsyna VB; Shatskaia MA; Ivanov AS; Archakov AI
Biomed Khim; 2012; 58(1):50-64. PubMed ID: 22642152
[TBL] [Abstract][Full Text] [Related]
22. Structural comparison of Escherichia coli L-asparaginase in two monoclinic space groups.
Sanches M; Barbosa JA; de Oliveira RT; Abrahão Neto J; Polikarpov I
Acta Crystallogr D Biol Crystallogr; 2003 Mar; 59(Pt 3):416-22. PubMed ID: 12595697
[TBL] [Abstract][Full Text] [Related]
23. Expression, purification and catalytic activity of Lupinus luteus asparagine beta-amidohydrolase and its Escherichia coli homolog.
Borek D; Michalska K; Brzezinski K; Kisiel A; Podkowinski J; Bonthron DT; Krowarsch D; Otlewski J; Jaskolski M
Eur J Biochem; 2004 Aug; 271(15):3215-26. PubMed ID: 15265041
[TBL] [Abstract][Full Text] [Related]
24. Amino acid residues adjacent to the catalytic cavity of tetramer L-asparaginase II contribute significantly to its catalytic efficiency and thermostability.
Long S; Zhang X; Rao Z; Chen K; Xu M; Yang T; Yang S
Enzyme Microb Technol; 2016 Jan; 82():15-22. PubMed ID: 26672444
[TBL] [Abstract][Full Text] [Related]
25. Identification of functional regions in the Rhodospirillum rubrum L-asparaginase by site-directed mutagenesis.
Pokrovskaya MV; Aleksandrova SS; Pokrovsky VS; Veselovsky AV; Grishin DV; Abakumova OY; Podobed OV; Mishin AA; Zhdanov DD; Sokolov NN
Mol Biotechnol; 2015 Mar; 57(3):251-64. PubMed ID: 25370827
[TBL] [Abstract][Full Text] [Related]
26. In silico characterization of a cyanobacterial plant-type isoaspartyl aminopeptidase/asparaginase.
da Silva RC; Siqueira AS; Lima ARJ; de Melo Lima A; Santos AS; Aguiar DCF; Gonçalves EC
J Mol Model; 2018 Apr; 24(5):108. PubMed ID: 29619654
[TBL] [Abstract][Full Text] [Related]
27. Rhizobium etli asparaginase II: an alternative for acute lymphoblastic leukemia (ALL) treatment.
Huerta-Saquero A; Evangelista-Martínez Z; Moreno-Enriquez A; Perez-Rueda E
Bioengineered; 2013; 4(1):30-6. PubMed ID: 22895060
[TBL] [Abstract][Full Text] [Related]
28. Site-specific mutagenesis of Escherichia coli asparaginase II. None of the three histidine residues is required for catalysis.
Wehner A; Harms E; Jennings MP; Beacham IR; Derst C; Bast P; Röhm KH
Eur J Biochem; 1992 Sep; 208(2):475-80. PubMed ID: 1521538
[TBL] [Abstract][Full Text] [Related]
29. Functional and structural evaluation of the antileukaemic enzyme L-asparaginase II expressed at low temperature by different Escherichia coli strains.
de Moura WAF; Schultz L; Breyer CA; de Oliveira ALP; Tairum CA; Fernandes GC; Toyama MH; Pessoa-Jr A; Monteiro G; de Oliveira MA
Biotechnol Lett; 2020 Nov; 42(11):2333-2344. PubMed ID: 32638188
[TBL] [Abstract][Full Text] [Related]
30. A novel L-asparaginase from Aquabacterium sp. A7-Y with self-cleavage activation.
Sun Z; Li D; Liu P; Wang W; Ji K; Huang Y; Cui Z
Antonie Van Leeuwenhoek; 2016 Jan; 109(1):121-30. PubMed ID: 26584939
[TBL] [Abstract][Full Text] [Related]
31. Crystal structure and amino acid sequence of Wolinella succinogenes L-asparaginase.
Lubkowski J; Palm GJ; Gilliland GL; Derst C; Röhm KH; Wlodawer A
Eur J Biochem; 1996 Oct; 241(1):201-7. PubMed ID: 8898907
[TBL] [Abstract][Full Text] [Related]
32. Structural and functional insights into Erwinia carotovora L-asparaginase.
Papageorgiou AC; Posypanova GA; Andersson CS; Sokolov NN; Krasotkina J
FEBS J; 2008 Sep; 275(17):4306-16. PubMed ID: 18647344
[TBL] [Abstract][Full Text] [Related]
33. A protease-resistant Escherichia coli asparaginase with outstanding stability and enhanced anti-leukaemic activity in vitro.
Maggi M; Mittelman SD; Parmentier JH; Colombo G; Meli M; Whitmire JM; Merrell DS; Whitelegge J; Scotti C
Sci Rep; 2017 Nov; 7(1):14479. PubMed ID: 29101342
[TBL] [Abstract][Full Text] [Related]
34. Engineering the substrate specificity of Escherichia coli asparaginase. II. Selective reduction of glutaminase activity by amino acid replacements at position 248.
Derst C; Henseling J; Röhm KH
Protein Sci; 2000 Oct; 9(10):2009-17. PubMed ID: 11106175
[TBL] [Abstract][Full Text] [Related]
35. Crystal structure of Escherichia coli L-asparaginase, an enzyme used in cancer therapy.
Swain AL; Jaskólski M; Housset D; Rao JK; Wlodawer A
Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1474-8. PubMed ID: 8434007
[TBL] [Abstract][Full Text] [Related]
36. Structure of Helicobacter pylori L-asparaginase at 1.4 A resolution.
Dhavala P; Papageorgiou AC
Acta Crystallogr D Biol Crystallogr; 2009 Dec; 65(Pt 12):1253-61. PubMed ID: 19966411
[TBL] [Abstract][Full Text] [Related]
37. Structural aspects of L-asparaginases, their friends and relations.
Michalska K; Jaskolski M
Acta Biochim Pol; 2006; 53(4):627-40. PubMed ID: 17143335
[TBL] [Abstract][Full Text] [Related]
38. Design and Characterization of Erwinia Chrysanthemi l-Asparaginase Variants with Diminished l-Glutaminase Activity.
Nguyen HA; Su Y; Lavie A
J Biol Chem; 2016 Aug; 291(34):17664-76. PubMed ID: 27354283
[TBL] [Abstract][Full Text] [Related]
39. Bacterial l-asparaginases for cancer therapy: Current knowledge and future perspectives.
Ghasemian A; Al-Marzoqi AH; Al-Abodi HR; Alghanimi YK; Kadhum SA; Shokouhi Mostafavi SK; Fattahi A
J Cell Physiol; 2019 Nov; 234(11):19271-19279. PubMed ID: 30993718
[TBL] [Abstract][Full Text] [Related]
40. [Suppression of telomerase activity leukemic cells by mutant forms of Rhodospirillum rubrum L-asparaginase].
Pokrovskaya MV; Zhdanov DD; Eldarov MA; Aleksandrova SS; Veselovskiy AV; Pokrovskiy VS; Grishin DV; Gladilina JA; Sokolov NN
Biomed Khim; 2017 Jan; 63(1):62-74. PubMed ID: 28251953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
